文献
J-GLOBAL ID:201802219897332737
整理番号:18A1140136
腫瘍免疫微小環境を再プログラミングすることによりCTLA-4遮断を補完するMEK阻害剤セルメme【JST・京大機械翻訳】
The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment
著者 (18件):
Poon Edmund
(MedImmune Ltd, Granta Park, Cambridge, UK)
,
Mullins Stefanie
(MedImmune Ltd, Granta Park, Cambridge, UK)
,
Watkins Amanda
(MedImmune Ltd, Granta Park, Cambridge, UK)
,
Williams Geoffrey S.
(MedImmune Ltd, Granta Park, Cambridge, UK)
,
Koopmann Jens-Oliver
(MedImmune Ltd, Granta Park, Cambridge, UK)
,
Genova Gianfranco Di
(AstraZeneca Ltd, Cambridge, UK)
,
Cumberbatch Marie
(AstraZeneca Ltd, Cambridge, UK)
,
Cumberbatch Marie
(New address: Immune Insight Ltd, Biohub, Cheshire, UK)
,
Veldman-Jones Margaret
(AstraZeneca Ltd, Cambridge, UK)
,
Grosskurth Shaun E.
(AstraZeneca Ltd, Waltham, USA)
,
Grosskurth Shaun E.
(New address: Abbvie Inc, North Chicago, USA)
,
Sah Vasu
(AstraZeneca Ltd, Waltham, USA)
,
Schuller Alwin
(AstraZeneca Ltd, Waltham, USA)
,
Reimer Corrine
(AstraZeneca Ltd, Waltham, USA)
,
Dovedi Simon J.
(MedImmune Ltd, Granta Park, Cambridge, UK)
,
Smith Paul D.
(AstraZeneca Ltd, Cambridge, UK)
,
Stewart Ross
(MedImmune Ltd, Granta Park, Cambridge, UK)
,
Wilkinson Robert W.
(MedImmune Ltd, Granta Park, Cambridge, UK)
資料名:
Journal for ImmunoTherapy of Cancer (Web)
(Journal for ImmunoTherapy of Cancer (Web))
巻:
5
号:
1
ページ:
63
発行年:
2017年
JST資料番号:
U7507A
ISSN:
2051-1426
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)